Contrastingly, in acute promyelocytic leukemia (APL) cells, overexpression of SIRPα exhibits distinct effects, potentially inhibiting the β-catenin signaling pathway and upregulating Foxo3a expression, which in turn induces apoptosis and inhibits tumor cell proliferation (63). The gene discussed is SIRPA; the disease is neoplasm.